Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5,434,244
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
16,477,324
-
Shares change
-
+3,007,463
-
Total reported value, excl. options
-
$638,906,382
-
Value change
-
+$117,351,300
-
Number of buys
-
47
-
Number of sells
-
-19
-
Price
-
$38.78
Significant Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q2 2020
72 filings reported holding APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q2 2020.
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,477,324 shares
.
Largest 10 shareholders include FMR LLC (3,158,207 shares), Redmile Group, LLC (2,268,718 shares), 5AM Venture Management, LLC (2,212,654 shares), Versant Venture Management, LLC (1,854,229 shares), Consonance Capital Management LP (1,252,185 shares), JANUS HENDERSON GROUP PLC (944,594 shares), Sectoral Asset Management Inc (915,681 shares), VANGUARD GROUP INC (604,377 shares), Rock Springs Capital Management LP (518,290 shares), and BlackRock Inc. (479,500 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.